Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.57552 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.57688 | 60 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.32623 | 54 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.50895 | 59 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.51343 | 59 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.60606 | 58 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.56468 | 58 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.55273 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.74228 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.06622 | 67 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.56187 | 59 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.5573 | 60 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.70525 | 62 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.56981 | 60 |